STOCKHOLM, SE/ ACCESSWIRE/ November 16, 2022/ Vimian Group (STO: VIMIAN) Enhanced market positions in tough macroeconomy
-
Profits increased by 70.9 percent to EUR 70.9 m (41.5 ), of which 5.2 percent was natural development (8.3 percent leaving out Diagnostics)
-
Changed EBITA EUR 17.2 m (11.6 ), representing an adjusted EBITA margin of 24.3 percent (27.9 )
-
Operating revenue amounted to EUR 8.8 m (4.5 ), consisting of products impacting comparability of EUR -3.6 m (-4.0 ). Revenue for the quarter amounted to EUR 1.6 m (-0.3 )
-
Revenues per share prior to dilution EUR -0.00 (-0.00) and after dilution EUR 0.00 (-0.00 )
” In the 3rd quarter, we reinforced our international market positions in a rough macroeconomic environment. Overall earnings grew by 70.9 percent to EUR 70.9 million, with an adjusted EBITA margin of 24.3 percent showing combination of gotten business. Our buddy animal companies provided strong 8.3 percent natural development in the 3rd quarter and 9.5 percent for the complete 9 months duration”, states Dr. Fredrik Ullman, CEO of Vimian Group.
Last twelve months pro-forma incomes (consisting of the complete year effect of all acquisitions finished throughout the twelve months ending 30 September) reached EUR 288.4 million and pro-forma EBITDA EUR 82.7 million.
” We continued our journey constructing an international, leading animal health business and reached pro-forma incomes of EUR 288.4 million with an adjusted EBITDA of EUR 82.7 million for the previous twelve months. In October, we effectively finished a SEK 1.5 billion capital raise to fund tactical acquisitions and decrease insolvency”, states Dr. Fredrik Ullman, CEO of Vimian Group.
A telephone and web conference will be held for financiers, experts, and media, today at 09.00 (CET). The conference will be kept in English and consist of a question-and-answer session.
To participate in the telephone conference:
SE: +46 856642695
UK: UK +44 333300080 4 (UK pin code: 61572279 #)
United States: +1 6467224956
To participate in the webcast:
Link: https://ir.financialhearings.com/vimian-group-q3-2022
Associated discussion products will be offered on Vimian’s site (https://vimian.com/investors/reports-and-presentations/) ahead of the telephone and web conference.
For more details, please contact:
Maria Dahllöf Tullberg
Head of IR, Communications & & Sustainability
[email protected]
+46 736 26 88 86
About Vimian
Vimian is an international, fast-growing group of innovation-driven business with a shared enthusiasm for making a favorable effect through enhancing animal health. Together, we put science, innovation and our clients’ requirements at the centre of whatever we do to provide efficient options to veterinary specialists, laboratories and animal moms and dads worldwide. We combine pioneering and entrepreneurial companies in animal health, with an objective to develop a distinctively varied proposal of services and products of the greatest requirement. Our group covers 4 necessary and quickly developing locations within animal health: Specialized Pharma, Diagnostics, Veterinary Providers and MedTech. Vimian offers specific companies with access to our networks, knowledge, facilities and capital to speed up development and development. We are as enthusiastic about supporting management within our existing companies, as we have to do with inviting brand-new partners to the Vimian household – together assisting us make an even higher effect by enhancing animal health. Headquartered in Stockholm, Sweden, Vimian and our household of business reach over 15,000 clients in +150 markets, utilize more than 700 individuals and have a combined yearly turnover of roughly EUR 170 million. FNCA Sweden AB is selected the Business’s Qualified Advisor, [email protected]. To learn more, please check out: www.vimian.com.
This details is details that Vimian Group is required to reveal pursuant to the EU Market Abuse Policy. The details was sent for publication, through the firm of the contact individuals set out above, at 2022-11-16 07:45 CET.
Accessories
Vimian Q3 Report
Vimian Q3 Discussion
SOURCE: Vimian Group
View source variation on accesswire.com:
https://www.accesswire.com/726190/Vimians-Interim-Report-for-the-Third-Quarter-of-2022
